OCUL - CIK 0001393434
The table below shows OCULAR THERAPEUTIX, INC's balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $666.70M | $344.77M | $391.13M | $349.68M | $427.22M | $459.69M |
| Short-term investments | - | - | - | - | - | - |
| Receivables | $24.35M | $30.77M | $30.41M | $25.22M | $30.23M | $30.23M |
| Inventory | $3.74M | $3.49M | $3.04M | $3.27M | $2.40M | $2.55M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current assets |
| $706.00M |
| $386.98M |
| $433.38M |
| $387.69M |
| $473.01M |
| $498.58M |
| Property, plant & equipment | $18.43M | $16.95M | $10.46M | $10.78M | $10.05M | $10.89M |
| Goodwill | - | - | - | - | - | - |
| Total assets | $732.53M | $410.88M | $451.33M | $405.92M | $490.37M | $517.09M |
| Accounts payable | $8.03M | $6.26M | $5.89M | $4.63M | $4.00M | $3.69M |
| Total current liabilities | $47.68M | $49.29M | $42.93M | $37.93M | $36.36M | $29.97M |
| Long-term debt | - | - | - | - | - | - |
| Total liabilities | $150.96M | $152.65M | $145.42M | $139.99M | $138.35M | $139.40M |
| Retained earnings | -$1.25B | -$1.09B | -$1.02B | -$955.14M | -$842.70M | -$806.20M |
| Total equity | $581.57M | $258.23M | $305.92M | $265.93M | $352.02M | $377.69M |